Cellosaurus HO-323-3 (CVCL_B6C9)
Cell line name | HO-323-3 |
---|---|
Accession | CVCL_B6C9 |
Resource Identification Initiative | To cite this cell line use: HO-323-3 (RRID:CVCL_B6C9) |
Comments | Group: Hybridoma fusion partner cell line. Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Spleen; UBERON=UBERON_0002106. |
Sequence variations |
|
Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_Z045 (HO-323) |
Sex of cell | Male |
Age at sampling | 5Y |
Category | Transformed cell line |
Publications | PubMed=22359119; DOI=10.1007/BF00145026 PubMed=22359170; DOI=10.1007/BF00365080 PubMed=1368811; DOI=10.1007/BF02525493 |
Cross-references | |
Encyclopedic resources | Wikidata; Q111733443 |
Entry history | |
Entry creation | 17-Mar-2022 |
Last entry update | 29-Jun-2023 |
Version number | 4 |